Taking people in Spanyolország2. fázis
Long-term follow-up of patients previously treated with autologous T cells genetically modified with viral vectors.
Key facts
- Where
- Barcelona, Madrid és Valencia, SpanyolországSee the 3 sites
- Phase
- 2. fázis
Where in Spanyolország
- Hospital Universitari Vall d'HebronBarcelona, SpanyolországTaking people
- Hospital Infantil Universitario Nino JesusMadrid, SpanyolországTaking people
- Hospital Universitario Y Politecnico La FeValencia, SpanyolországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Autolus Limited
- Trial code
- EU 2024-511684-28-00
- Record updated
- 2026. március 18.
- Original description
Long-term safetyRead full original descriptionShow less
Long-term safety
Inclusion: Patients must have received an AUTO CAR T cell therapy on a previous treatment study; Patients must have provided informed consent for long-term follow-up study prior to participation; Patients must be able to comply with the study requirements.
Exclusion: There are no exclusion criteria for this study.